Notably, and clinically relevant, T2DM vs non-T2DM over-expressed at baseline, and at 5 years of follow-up, the inflammatory cytokines (IL-1, IL-6, TNF-α). This evidence concerns the gene IL6 and type 2 diabetes mellitus.